BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 23666431)

  • 1. Brain stem tumors in children and adolescents: single institutional experience.
    Garzón M; García-Fructuoso G; Guillén A; Suñol M; Mora J; Cruz O
    Childs Nerv Syst; 2013 Aug; 29(8):1321-31. PubMed ID: 23666431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pseudoprogression in children, adolescents and young adults with non-brainstem high grade glioma and diffuse intrinsic pontine glioma.
    Carceller F; Fowkes LA; Khabra K; Moreno L; Saran F; Burford A; Mackay A; Jones DT; Hovestadt V; Marshall LV; Vaidya S; Mandeville H; Jerome N; Bridges LR; Laxton R; Al-Sarraj S; Pfister SM; Leach MO; Pearson AD; Jones C; Koh DM; Zacharoulis S
    J Neurooncol; 2016 Aug; 129(1):109-21. PubMed ID: 27180091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management and outcome of focal low-grade brainstem tumors in pediatric patients: the St. Jude experience.
    Klimo P; Pai Panandiker AS; Thompson CJ; Boop FA; Qaddoumi I; Gajjar A; Armstrong GT; Ellison DW; Kun LE; Ogg RJ; Sanford RA
    J Neurosurg Pediatr; 2013 Mar; 11(3):274-81. PubMed ID: 23289916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A clinicopathologic reappraisal of brain stem tumor classification. Identification of pilocystic astrocytoma and fibrillary astrocytoma as distinct entities.
    Fisher PG; Breiter SN; Carson BS; Wharam MD; Williams JA; Weingart JD; Foer DR; Goldthwaite PT; Tihan T; Burger PC
    Cancer; 2000 Oct; 89(7):1569-76. PubMed ID: 11013373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diffusion-weighted MRI derived apparent diffusion coefficient identifies prognostically distinct subgroups of pediatric diffuse intrinsic pontine glioma.
    Lober RM; Cho YJ; Tang Y; Barnes PD; Edwards MS; Vogel H; Fisher PG; Monje M; Yeom KW
    J Neurooncol; 2014 Mar; 117(1):175-82. PubMed ID: 24522717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A phase 2 study of valproic acid and radiation, followed by maintenance valproic acid and bevacizumab in children with newly diagnosed diffuse intrinsic pontine glioma or high-grade glioma.
    Su JM; Murray JC; McNall-Knapp RY; Bowers DC; Shah S; Adesina AM; Paulino AC; Jo E; Mo Q; Baxter PA; Blaney SM
    Pediatr Blood Cancer; 2020 Jun; 67(6):e28283. PubMed ID: 32285998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A pediatric trial of radiation/cetuximab followed by irinotecan/cetuximab in newly diagnosed diffuse pontine gliomas and high-grade astrocytomas: A Pediatric Oncology Experimental Therapeutics Investigators' Consortium study.
    Macy ME; Kieran MW; Chi SN; Cohen KJ; MacDonald TJ; Smith AA; Etzl MM; Kuei MC; Donson AM; Gore L; DiRenzo J; Trippett TM; Ostrovnaya I; Narendran A; Foreman NK; Dunkel IJ
    Pediatr Blood Cancer; 2017 Nov; 64(11):. PubMed ID: 28544128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Malignant brainstem tumors in children, excluding diffuse intrinsic pontine gliomas.
    Klimo P; Nesvick CL; Broniscer A; Orr BA; Choudhri AF
    J Neurosurg Pediatr; 2016 Jan; 17(1):57-65. PubMed ID: 26474099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A pilot study of bevacizumab-based therapy in patients with newly diagnosed high-grade gliomas and diffuse intrinsic pontine gliomas.
    Hummel TR; Salloum R; Drissi R; Kumar S; Sobo M; Goldman S; Pai A; Leach J; Lane A; Pruitt D; Sutton M; Chow LM; Grimme L; Doughman R; Backus L; Miles L; Stevenson C; Fouladi M; DeWire M
    J Neurooncol; 2016 Mar; 127(1):53-61. PubMed ID: 26626490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A phase I/II study of ribociclib following radiation therapy in children with newly diagnosed diffuse intrinsic pontine glioma (DIPG).
    DeWire M; Fuller C; Hummel TR; Chow LML; Salloum R; de Blank P; Pater L; Lawson S; Zhu X; Dexheimer P; Carle AC; Kumar SS; Drissi R; Stevenson CB; Lane A; Breneman J; Witte D; Jones BV; Leach JL; Fouladi M
    J Neurooncol; 2020 Sep; 149(3):511-522. PubMed ID: 33034839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of telomere maintenance mechanisms in pediatric high-grade gliomas.
    Dorris K; Sobo M; Onar-Thomas A; Panditharatna E; Stevenson CB; Gardner SL; Dewire MD; Pierson CR; Olshefski R; Rempel SA; Goldman S; Miles L; Fouladi M; Drissi R
    J Neurooncol; 2014 Mar; 117(1):67-76. PubMed ID: 24477622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ketogenic diet treatment in diffuse intrinsic pontine glioma in children: Retrospective analysis of feasibility, safety, and survival data.
    Perez A; van der Louw E; Nathan J; El-Ayadi M; Golay H; Korff C; Ansari M; Catsman-Berrevoets C; von Bueren AO
    Cancer Rep (Hoboken); 2021 Oct; 4(5):e1383. PubMed ID: 33939330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pontine gliomas a 10-year population-based study: a report from The Canadian Paediatric Brain Tumour Consortium (CPBTC).
    Fonseca A; Afzal S; Bowes L; Crooks B; Larouche V; Jabado N; Perreault S; Johnston DL; Zelcer S; Fleming A; Scheinemann K; Silva M; Vanan MI; Mpofu C; Wilson B; Eisenstat DD; Lafay-Cousin L; Hukin J; Hawkins C; Bartels U; Bouffet E
    J Neurooncol; 2020 Aug; 149(1):45-54. PubMed ID: 32632896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Children with DIPG and high-grade glioma treated with temozolomide, irinotecan, and bevacizumab: the Seattle Children's Hospital experience.
    Crotty EE; Leary SES; Geyer JR; Olson JM; Millard NE; Sato AA; Ermoian RP; Cole BL; Lockwood CM; Paulson VA; Browd SR; Ellenbogen RG; Hauptman JS; Lee A; Ojemann JG; Vitanza NA
    J Neurooncol; 2020 Jul; 148(3):607-617. PubMed ID: 32556862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diffuse intrinsic pontine glioma in children and adolescents: a single-center experience.
    Vallero SG; Bertin D; Basso ME; Pittana LS; Mussano A; Fagioli F
    Childs Nerv Syst; 2014 Jun; 30(6):1061-6. PubMed ID: 24420674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diffuse intrinsic pontine gliomas in adults: A retrospective study.
    Kandregula S; Konar S; Sadashiva N; Nagesh M; Kalahasti SR; Krishna U; Saini J; Shukla D; Santosh V
    Neurol India; 2022; 70(2):584-590. PubMed ID: 35532623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinicopathological characteristics and prognosis of diffuse midline gliomas with histone H3K27M mutation: an analysis of 30 cases].
    Li HN; Shan CG; Fan CZ; Cheng LN; Wu SG; Liu MT; Jiang GY; Li Z
    Zhonghua Bing Li Xue Za Zhi; 2019 Mar; 48(3):192-198. PubMed ID: 30831644
    [No Abstract]   [Full Text] [Related]  

  • 18. Histologically proven, low-grade brainstem gliomas in children: 30-year experience with long-term follow-up at Mayo Clinic.
    Ahmed KA; Laack NN; Eckel LJ; Orme NM; Wetjen NM
    Am J Clin Oncol; 2014 Feb; 37(1):51-6. PubMed ID: 23357966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-grade gliomas in children: single institutional experience in 198 cases.
    Garzón M; García-Fructuoso G; Suñol M; Mora J; Cruz O
    Childs Nerv Syst; 2015 Sep; 31(9):1447-59. PubMed ID: 26156776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Secondary dissemination in children with high-grade malignant gliomas and diffuse intrinsic pontine gliomas.
    Wagner S; Benesch M; Berthold F; Gnekow AK; Rutkowski S; Sträter R; Warmuth-Metz M; Kortmann RD; Pietsch T; Wolff JE
    Br J Cancer; 2006 Oct; 95(8):991-7. PubMed ID: 17047647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.